Pricing Log in Create free account

Actuate Therapeutics, Inc. (ACTU) vs Context Therapeutics Inc. (CNTX)

Actuate Therapeutics, Inc. and Context Therapeutics Inc. are both Biotechnology companies. Actuate Therapeutics, Inc. and Context Therapeutics Inc. are of similar size ($18.0M and $17.3M). Across the 8 metrics below, Context Therapeutics Inc. leads on 5 and Actuate Therapeutics, Inc. on 3.

Valuation

Metric ACTU CNTX Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 7.72 0.47 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.51 0.66
EV/Sales n/m n/m 9.02
Earnings yield (271.88%) (252.63%) (32.88%)
Free cash flow yield (259.67%) (188.15%) (23.13%)

Profitability

Metric ACTU CNTX Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 2,457.65% (76.14%) (51.96%)
Return on assets (336.18%) (68.96%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ACTU CNTX Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 67.48% 17.39% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ACTU CNTX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.25 5.81 4.97
Net debt to EBITDA 0.59 1.66 1.01

Dividend

Metric ACTU CNTX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ACTU CNTX Biotechnology median
Market cap 17.98m 17.27m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack